Drug disposition in old age
New England Journal of Medicine 307(17): 1087-1089
1982
ISSN/ISBN: 0028-4793 PMID: 7121526 Document Number: 187506
Document emailed within 1 workday
Related Documents
Maftouh, M.; Monsarrat, B.; Rao, R.C.; Meunier, B.; Paoletti, C. 1984: Identification of the glucuronide and glutathione conjugates of the antitumor drug N2-methyl-9-hydroxyellipticinium acetate (Celiptium). Comparative disposition of this drug with its olivacinium isomer in rat bile Drug Metabolism and Disposition: the Biological Fate of Chemicals 12(1): 111-119Morselli, P.L. 1974: Drug disposition during development Acta Pharmaceutica Suecica 11(6): 647
Hogan, L. 1982: Drug disposition in the elderly Journal of the Kansas Medical Society 83(7): 380
Yerby, M.S.; Friel, P.N.; McCormick, K. 1992: Antiepileptic drug disposition during pregnancy Neurology 42(4 Suppl 5: 12-16
Yaffe, S.J. 1973: Drug disposition in the fetus and newborn infant Rhode Island Medical Journal 56(7): 280-285 Passim
Stewart, C.F.; Hampton, E.M. 1987: Effect of maturation on drug disposition in pediatric patients Clinical Pharmacy 6(7): 548-564
Riska, P.; Lamson, M.; MacGregor, T.; Sabo, J.; Hattox, S.; Pav, J.; Keirns, J. 1999: Disposition and biotransformation of the antiretroviral drug nevirapine in humans Drug Metabolism and Disposition: the Biological Fate of Chemicals 27(8): 895-901
Wu, X.-m.; Sheng, L.; Jia, Y.-f.; Li, Y. 2016: Role of breast cancer resistance protein in drug disposition Yao Xue Xue Bao 51(9): 1368-1377
Verbeeck, R.K. 1982: Glucuronidation and disposition of drug glucuronides in patients with renal failure. a review Drug Metabolism and Disposition: the Biological Fate of Chemicals 10(1): 87-89
Pochapsky, S.S.; Pochapsky, T.C. 2001: Nuclear magnetic resonance as a tool in drug discovery, metabolism and disposition Current Topics in Medicinal Chemistry 1(5): 427-441
Kawai, K.; Kawasaki-Tokui, Y.; Odaka, T.; Tsuruta, F.; Kazui, M.; Iwabuchi, H.; Nakamura, T.; Kinoshita, T.; Ikeda, T.; Yoshioka, T.; Komai, T.; Nakamura, K. 1997: Disposition and metabolism of the new oral antidiabetic drug troglitazone in rats, mice and dogs Arzneimittel-Forschung 47(4): 356-368
Dorr, R.T.; Alberts, D.S. 1985: Vinca alkaloid skin toxicity: antidote and drug disposition studies in the mouse Journal of the National Cancer Institute 74(1): 113-120
Vaden, S.L.; Page, R.L.; Peters, B.P.; Cline, J.M.; Riviere, J.E. 1993: Development and characterization of an isolated and perfused tumor and skin preparation for evaluation of drug disposition Cancer Research 53(1): 101-105
Manning, B.W.; Franklin, M.R.; Galinsky, R.E. 1991: Drug metabolizing enzyme changes after chronic buthionine sulfoximine exposure modify acetaminophen disposition in rats Drug Metabolism and Disposition: the Biological Fate of Chemicals 19(2): 498-502
Andersson, M.L.; Böttiger, Y.; Lindh, J.D.; Wettermark, B.; Eiermann, B. 2013: Impact of the drug-drug interaction database SFINX on prevalence of potentially serious drug-drug interactions in primary health care European Journal of Clinical Pharmacology 69(3): 565-571
Nishikaze, O. 1975: Drug-drug interaction and drug-induced interference with clinical laboratory test procedures--chairman's introductory remarks Rinsho Byori. Japanese Journal of Clinical Pathology 23(2): 75
Hsu, R.S.; Sikka, H.C. 1982: Disposition of 3,3'-dichlorobenzidine in the rat Toxicology and Applied Pharmacology 64(2): 306-316
Taylor, T.; Cameron, B.D.; Hathway, D.E.; Partington, H. 1974: The disposition of pantothenate in dogs Research in Veterinary Science 16(3): 271-275
Musch, A. 2006: Lipid disposition in the skin Medizinische Monatsschrift für Pharmazeuten 29(2): 71-72
Matsunaga, Y.; Miyazaki, H.; Oh-e, Y.; Nambu, K.; Furukawa, H.; Yoshida, K.; Hashimoto, M. 1991: Disposition and metabolism of [14C]sparfloxacin in the rat Arzneimittel-Forschung 41(7): 747-759